Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects [Phase 1, Phase 2]
Phase 1/2 trial assessing tolerability, pharmacokinetics, and pharmacodynamics of HEC110114 tablets in subjects with chronic hepatitis C; st…
-
CLINICAL_TRIALS trial_result · 2020-09-07Clinical Trial Update: Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis [Phase 3]
Phase 3 trial of elbasvir/grazoprevir fixed-dose combo for 8 weeks in treatment-naïve patients with HCV genotype 1b and non-severe fibrosis …
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol [Phase 1]
Phase 1 study evaluating the pharmacokinetic interaction between sofosbuvir/velpatasvir/GS-9857 and a hormonal contraceptive (norgestimate/e…
-
CLINICAL_TRIALS trial_result · 2020-08-31Clinical Trial Update: Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection [Phase 2]
Phase 2 study assessing pharmacokinetics, safety, and efficacy of SOF/VEL/VOX fixed-dose combination in adolescents and children with chroni…
-
FDA approval · 2020-08-27FDA Approved: SOVALDI — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Sovaldi (sofosbuvir) from Gilead Sciences, Inc. The approval updates the product’s labeling/indi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED) [Phase 3]
Phase 3 trial evaluating the effect of infliximab on the efficacy of Peg-Intron/ribavirin in chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors [Phase 4]
Phase 4 clinical trial evaluating renal transplants from nucleic acid positive donors to hepatitis C negative recipients; completed with pos…
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection [Phase 1]
Phase 1 trial evaluating safety, tolerability, pharmacokinetics, and antiviral activity of voxilaprevir in adults with chronic hepatitis C v…
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Elbasvir (EBR)/Grazoprevir (GZR) in Pediatric Participants With Chronic Hepatitis C Infection (MK-5172-079) [Phase 2]
Phase 2 pediatric trial updating Elbasvir/Grazoprevir for chronic hepatitis C infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-28Clinical Trial Update: Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects. [Phase 2, Phase 3]
A Phase 2/3 trial evaluating Ravidasvir with Danoprevir/r and ribavirin in treatment-naive, non-cirrhotic chronic hepatitis C genotype 1 pat…
-
FDA label_change · 2020-07-14FDA Approved: EPCLUSA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Epclusa (velpatasvir/sofosbuvir) from Gilead to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis [Phase 3]
Phase 3 trial update of glecaprevir/pibrentasvir in treatment-naive adults with chronic HCV infection (genotypes 1-6) and compensated cirrho…
-
CLINICAL_TRIALS trial_result · 2020-07-10Clinical Trial Update: Micro-elimination of Hepatitis C Virus Infection in Uremics [Phase 3]
Phase 3 clinical trial update on micro-elimination of hepatitis C virus infection in uremic patients.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Effect of Hepatitis C Clearance on Insulin Resistance [Phase 4]
Phase 4 trial evaluating the effect of Hepatitis C clearance on insulin resistance.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety, tolerability, and antiviral activity of chlorcyclizine HCl in chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2020-05-18Clinical Trial Update: Sofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a Sofosbuvir/Ombitasvir/Paritaprevir/Ritonavir combination with Ribavirin for chronic Hepatitis C Virus …
-
CLINICAL_TRIALS trial_result · 2020-05-15Clinical Trial Update: Sofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4 [Phase 2, Phase 3]
Phase 2/3 trial evaluating sofosbuvir plus daclatasvir with or without ribavirin for chronic hepatitis C virus infection genotype 4 complete…
-
CLINICAL_TRIALS trial_result · 2020-05-14Clinical Trial Update: ٍٍSofosbuvir/Simeprevir/Daclatasvir/Ribavirin and HCV Genotype 4-infected Egyptian Experienced Participants [Phase 1, Phase 2]
Phase 1/2 trial evaluating a four-drug regimen (sofosbuvir, simeprevir, daclatasvir, ribavirin) in Egyptian participants with chronic hepati…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Sofosbuvir With Ribavirin or Simeprevir With HCV GT4 Egyptian Patients [Phase 2]
Phase 2 trial update evaluating sofosbuvir with ribavirin or simeprevir in Egyptian patients with chronic hepatitis C virus infection has co…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Ombitasvir /Paritaprevir/Ritonavir Plus Ribavirin on HCV GT4 [Phase 1, Phase 2]
Clinical trial update on Ombitasvir/Paritaprevir/Ritonavir plus Ribavirin for Hepatitis C Virus Infection in Phase 1 and Phase 2, status com…
-
CLINICAL_TRIALS trial_result · 2020-05-11Clinical Trial Update: Sofosbuvir/Pegylated-interferon Plus Ribavirin With HCV Genotype 4 [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating Sofosbuvir/Pegylated-interferon plus Ribavirin in Hepatitis C Virus Infection (Genotype 4).
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection [Phase 2]
Phase 2 trial investigating AT-527 in combination with daclatasvir for hepatitis C virus infection has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Undiagnosed Hepatitis C Infection in an Urban Hospital
Clinical trial update on undiagnosed hepatitis C infection in an urban hospital; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: Hepatitis C Virus(HCV) Heart and Lung Study [Phase 4]
Phase 4 clinical trial update for an HCV-related heart and lung study; results have been posted after completion.
-
CLINICAL_TRIALS withdrawal · 2020-04-20Clinical Trial Update: Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4 [Phase 4]
Phase 4 clinical trial targeting elimination of HCV infection in treatment-naïve, renally impaired Egyptian patients on dialysis has been wi…